IDEX에 대한 매도 수량은 투자자에게 IDEX의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

IDEX (NYSE:IEX) 주식, 공매도 수량 보고

IDEX CORP

IDEX

Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.

paypal-shutter2

Equities

Large Cap

News

Movers

Trading Ideas

AVTR

ILMN

MRNA

NBIX

PYPL

SWKS

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 스카이웍스 솔루션(NASDAQ:SWKS)의 주식은 회사가 1분기 실적을 발표하고 2분기 가이던스를 예상치 이하로 제시한 후 25.99% 하락했다. 애널리스트들은 주가 전망을 수정했다.

에스티 로더, 모더나 및 페이팔 등 지난주 하락한 10개의 대형주 (2월 3일-7일)

IDEX Corp

iExalt Inc

iExec - United States Dollar

WIIM

AGCO

ATMU

CMCO

GTES

GTLS

HLMN

INLF

LECO

MIDD

NDSN

PCAR

RAIL

RAIN

Shares of machinery companies are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate some supply chain concerns and improve macro sentiment as well as demand visibility.

RBC Capital analyst Deane Dray maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Outperform and raises the price target from $206 to $208.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on IDEX, Raises Price Target to $208

Stifel analyst Nathan Jones maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Buy and raises the price target from $192 to $208.

Stifel Maintains Buy on IDEX, Raises Price Target to $208

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) affirms FY2025 Adj EPS guidance from $8.10-$8.45 to $8.10-$8.45 vs $8.11 analyst estimate..

Guidance

IDEX Affirms FY2025 Adj EPS Guidance of $8.10-$8.45 vs $8.11 Est

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) narrows FY2025 GAAP EPS guidance from $6.56-$6.96 to $6.56-$6.95 vs $6.80 analyst estimate..

IDEX Narrows FY2025 GAAP EPS Guidance from $6.56-$6.96 to $6.56-$6.95 vs $6.80 Est

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) is looking for Q2 Adj EPS of $1.95-$2.05 vs $2.10 analyst estimate..

IDEX Sees Q2 Adj EPS $1.95-$2.05 vs $2.10 Est

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) is looking for Q2 GAAP EPS of $1.60-$1.72 vs $1.76 analyst estimate..

IDEX Sees Q2 GAAP EPS $1.60-$1.72 vs $1.76 Est

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.63 by 7.36 percent. This is a 6.91 percent decrease over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $814.30 million which beat the analyst consensus estimate of $807.19 million by 0.88 percent. This is a 1.72 percent increase over sales of $800.50 million the same period last year.

Earnings

Earnings Beats

IDEX Q1 Adj. EPS $1.75 Beats $1.63 Estimate, Sales $814.30M Beat $807.19M Estimate

AAMI

AAPL

ABNB

ACCO

ADPT

AGIO

ALHC

ALKS

ALNY

ALSN

AMGN

AMWL

AMZN

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CARR

CART

CERS

CMLS

COHN

COHU

COLM

COMM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

DXCM

ECVT

ELME

Earnings Scheduled For May 1, 2025

Citigroup analyst Vladimir Bystricky maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Buy and lowers the price target from $264 to $201.

Citigroup Maintains Buy on IDEX, Lowers Price Target to $201

Stifel analyst Nathan Jones maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Buy and lowers the price target from $256 to $192.

Stifel Maintains Buy on IDEX, Lowers Price Target to $192

CVGI

HLIO

JBTM

TWIN

Shares of machinery companies are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

ASTE

BLBD

EPAC

ESAB

FELE

FSTR

LXFR

OTIS

PDYN

PRLB

SPXC

UGRO

WPRT

Shares of machinery companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Embraer-Empresa Brasileira De Aeronautica

FTAI

GEHC

RKLB

Shares of industrial stocks are trading lower amid macroeconomic concerns due to rising global trade tensions.

KRNT

LASE

MVST

Shares of machinery stocks are trading lower as markets react to President Trump's announcement of sweeping tariffs.

DA Davidson analyst Matt Summerville maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Neutral and lowers the price target from $225 to $215.

DA Davidson Maintains Neutral on IDEX, Lowers Price Target to $215

It was revealed in a recent SEC filing that Melissa S Flores, SVP at IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) made a noteworthy insider purchase on February 13,.
What Happened: In a significant move reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000832101/000090514825000572//Archives/edgar/data/832101/000090514825000572/0000905148-25-000572-index.htm">U.S. Securities and Exchange Commission</a> on Thursday, Flores purchased 777 shares of IDEX, demonstrating confidence in the company's growth potential. The total value of the transaction stands at $152,641.
At Friday morning, IDEX shares are down by 0.0%, trading at $193.03.
<h3>Unveiling the Story Behind IDEX</h3>
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.
<h3>IDEX: A Financial Overview</h3>
Revenue Growth: Over the 3 months period, IDEX showcased positive performance, achieving a revenue growth rate of 0.6% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Exploring Profitability:
<ul>
<li>
Gross Margin: With a high gross margin of 44.34%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, IDEX exhibits below-average bottom-line performance with a current EPS of 1.57.
</li>
</ul>
Debt Management: IDEX's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.55.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 29.07, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 4.48 is above industry norms, reflecting an elevated valuation for IDEX's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 18.57 reflects market recognition of IDEX's value, positioning it as more highly valued compared to industry peers.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000832101">Check Out The Full List Of IDEX's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Noteworthy Insider Activity: Melissa S Flores Invests $152K In IDEX Stock

Roopa Unnikrishnan, SVP at IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>), reported an insider buy on February 13, according to a new SEC filing. 
What Happened: In a significant move reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000832101/000090514825000575//Archives/edgar/data/832101/000090514825000575/0000905148-25-000575-index.htm">U.S. Securities and Exchange Commission</a> on Thursday, Unnikrishnan purchased 657 shares of IDEX, demonstrating confidence in the company's growth potential. The total value of the transaction stands at $129,067.
Tracking the Friday's morning session, IDEX shares are trading at $193.03, showing a down of 0.0%.
<h3>About IDEX</h3>
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.
<h3>IDEX: Financial Performance Dissected</h3>
Positive Revenue Trend: Examining IDEX's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.6% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 44.34%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): IDEX's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 1.57.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.55, IDEX adopts a prudent financial strategy, indicating a balanced approach to debt management.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 29.07 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 4.48 is above industry norms, reflecting an elevated valuation for IDEX's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): IDEX's EV/EBITDA ratio stands at 18.57, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000832101">Check Out The Full List Of IDEX's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Roopa Unnikrishnan Takes a Bullish Stance: Acquires $129K In IDEX Stock

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) stock declined 25.99% after the company reported first-quarter earnings and issued second-quarter guidance below estimates. Analysts revised <a href="https://www.benzinga.com//node/43540329" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Estee Lauder Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) stock plummeted 22.05%  after the company <a href="https://www.benzinga.com//node/43462736" target="_blank" rel="noreferrer noopener">reported second-quarter results</a>. Several analysts lowered <a href="https://www.benzinga.com/quote/el/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Neurocrine Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) shares tumbled 19.23% after the company missed its fourth-quarter revenue <a href="https://www.benzinga.com//node/43544393" target="_blank" rel="noreferrer noopener">estimate when reporting financial results</a>. Additionally, HC Wainwright &amp; Co. and B of A Securities lowered <a href="https://www.benzinga.com/quote/nbix/analyst-ratings" target="_blank" rel="noreferrer noopener">their respective price forecasts on the stock</a>.</li>
<li>Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) shares fell 17.30%, probably after the Senate Finance Committee voted to advance Robert F. Kennedy Jr.&#8217;s nomination to the Senate floor.</li>
<li>Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) stock was down 16.33% after the company <a href="https://www.benzinga.com//node/43544682" target="_blank" rel="noreferrer noopener">reported fourth-quarter results</a>. Analysts lowered <a href="https://www.benzinga.com/quote/ilmn/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Venture Global, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VG#NYSE">VG</a>) stock decreased 14.23%, probably after President Trump reiterated a pledge to increase oil production.</li>
<li>Avantor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) shares declined 14.01% after the company reported fourth-quarter results and <a href="https://www.benzinga.com//node/43560312" target="_blank" rel="noreferrer noopener">missed its adjusted EPS estimate</a>.</li>
<li>PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) stock tumbled 12.72% after the company reported fourth-quarter results and analysts <a href="https://www.benzinga.com//node/43475080" target="_blank" rel="noreferrer noopener">revised the price forecast</a>.</li>
<li>IDEX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) shares fell 12.65% following mixed <a href="https://www.benzinga.com//node/43479651" target="_blank" rel="noreferrer noopener">fourth-quarter financial results</a>. Analysts revised <a href="https://www.benzinga.com/quote/iex/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>PTC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) shares declined 12.64% after the company reported first-quarter financial results, issued guidance below <a href="https://www.benzinga.com//node/43509190" target="_blank" rel="noreferrer noopener">estimates and cut its FY25 guidance</a>.</li>
</ol>
Photo by Lets Design Studio via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/02/43580845/palantir-super-micro-computer-and-spotify-are-among-top-10-large-cap-gainers-last-week-feb-3-feb-7-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Palantir, Super Micro Computer And Spotify Are Among Top 10 Large Cap Gainers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?</a></li>
</ul>

Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $259.0, a high estimate of $269.00, and a low estimate of $245.00. This current average has increased by 2.13% from the previous average price target of $253.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1738864844_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of IDEX's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$245.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Vladimir Bystricky</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$267.00</td>
<td>$269.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$256.00</td>
<td>$244.00</td>
</tr>
<tr>
<td>Vladimir Bystricky</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$269.00</td>
<td>$251.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$258.00</td>
<td>$248.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to IDEX. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of IDEX compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of IDEX's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of IDEX's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IEX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on IDEX analyst ratings.</a>
<h2>Delving into IDEX's Background</h2>
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.
<h3>IDEX's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: IDEX displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 0.6%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: IDEX's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 14.92%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): IDEX's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.19%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): IDEX's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.85%, the company may face hurdles in achieving optimal financial performance.
Debt Management: IDEX's debt-to-equity ratio is below the industry average. With a ratio of 0.55, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into IDEX Stock: Analyst Perspectives (5 Ratings)

Press Releases

IDEX Corporation Declares Regular Quarterly Cash Dividend

IDEX Corporation to Webcast Fourth Quarter 2024 Earnings Call

IDEX Reports Fourth Quarter and Full Year 2024 Results

IDEX Corporation Appoints Stephanie Disher and Matthijs Glastra to Board of Directors; David Parry and Livingston Satterthwaite to Retire

Helios Technologies Celebrates 15-Year Partnership Between Enovation Controls and IDEX Fire & Safety

Comments

IDEX

매도 수량

IDEX (NYSE:IEX) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌